The superalloy molybdenum-rhenium (MoRe) is a big part of why Boston Scientific is betting big on the MiRus Siegel TAVR heart ...

Boston Scientific Corporation (NYSE:BSX) is one of the oversold tech stocks to buy now. On May 18, Boston Scientific invested ...

Boston Scientific has made a $1.5 billion investment that could put it one step closer to acquiring a built-out TAVR system. Since 2020, the medtech giant has tried twice unsuccessfully to acquire an ...

In the US EFS, 15 patients with severe, symptomatic aortic stenosis (AS) were treated at Piedmont, Cedars Sinai, Stanford, Mayo Clinic and Naples. At 30 days, there were no deaths, strokes or ...

ATLANTA, March 28, 2025 /PRNewswire/ -- MiRus is pleased to announce the launch of the US multi-center Early Feasibility Study of the Siegel™ 8-Fr aortic transcatheter heart valve (THV). The first two ...

Boston Scientific stock has fallen 56.5% over the past year, yet the valuation checks still lean toward the shares looking ...

Bengaluru: U.S. medical device maker Boston Scientific said on Monday it has invested $1.5 billion in privately held MiRus LLC in return for a 34% equity stake and potential access to the startup's ...

Edwards TAVR data has a strong showing at NY Valves 2026 amid intense industry competition from Abbott Laboratories and Medtronic.

ATLANTA, July 2, 2025 /PRNewswire/ -- The MiRus Siegel™ Valve was featured in three podium presentations at the NY Valves meeting last week. Pradeep K. Yadav MD, Piedmont Heart Institute, Atlanta and ...

(MENAFN- PR Newswire) The Siegel valve represents several firsts in TAVR: 8 French delivery sheath allowing less invasive procedures and broader patient access, particularly for women; the only Nickel ...